Upgrade to SI Premium - Free Trial

Novo Nordisk (NVO) PT Raised to $160 at Argus

June 10, 2024 8:32 AM
Argus analyst John Eade raised the price target on Novo Nordisk (NYSE: NVO) to $160.00 (from $125.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles